Valuation
- Market cap
- 135,000
- Revenue TTM
- $12,230,000
- Net income TTM
- $-43,310,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -354.13%
- Debt to equity
- -1.16
Trading
- Volume
- 38,300
- Avg volume
- —
- Day's range
- $0.00 – $0.00
- Shares out
- 1,354,370,000
- Stochastic %K
- —
- Beta
- 0.05
- Analysts
- —
- Price target
- —
Company profile
Todos Medical Ltd., a vitro diagnostics company, engages in the development of novel blood tests for the early detection of cancer and neurodegenerative disorders. It offers COVID testing solutions and Provista diagnostics. The company also develops Videssa Breast, a cancer blood test; Lympro, an Alzheimer's blood test; TolloTest, a 3CL proteaste test; and TBIA, an AI cancer platform. In addition, it distributes a di...
Show more
Todos Medical Ltd., a vitro diagnostics company, engages in the development of novel blood tests for the early detection of cancer and neurodegenerative disorders. It offers COVID testing solutions and Provista diagnostics. The company also develops Videssa Breast, a cancer blood test; Lympro, an Alzheimer's blood test; TolloTest, a 3CL proteaste test; and TBIA, an AI cancer platform. In addition, it distributes a dietary supplement under the Tollovid name and develops Tollovir, a 3CL protease inhibitor as COVID anti-viral. The company was incorporated in 2010 and is based in Tel Aviv-Yafo, Israel.
- Industry
- Diagnostics & Research
- Sector
- Healthcare
- Phone
- 972 73 207 7259
- Website
- https://todosmedical.com
- Address
- 121 Derech Menachem Begin, 30th Floor, Tel Aviv, Israel
Latest news
No headlines yet.
